Future Fertility

News

It's no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents.

News

Novo Nordisk will file oral formulations of its GLP-1 agonist semaglutide for children and adolescents with type 2 diabetes later this year.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.